Atlas Trials

Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant

Clinical trial NCT05063071 · UNKNOWN

Trial details

NCT number
NCT05063071
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HBVPOST LIVER TRANSPLANT
Start date
2021-07-29
Primary completion
2022-07-29
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.